Contact DMCA Privacy

Robuta

https://pubmed.ncbi.nlm.nih.gov/25308571/
Shared decision making for hydroxyurea treatment initiation in children with sickle cell anemia
Clinical trials have demonstrated hydroxyurea's efficacy in improving health outcomes for children with sickle cell anemia (SCA) who have medical...
shared decision makinghydroxyureatreatmentinitiationchildren
https://www.wikidata.org/wiki/Q68499327
Hydroxyurea-sensitive mutants of bacteriophage T4 - Wikidata
scientific article published on 01 October 1972
hydroxyureasensitivemutantsbacteriophagewikidata
https://pubmed.ncbi.nlm.nih.gov/28053695/
Study on Hydroxyurea Response in Hemoglobinopathies Patients Using Genetic Markers and Liquid...
Increased expression of fetal hemoglobin (HbF) may ameliorate the clinical course of hemoglobinopathies. Hydroxyurea (HU) is the only inducer approved for the...
genetic markersstudyhydroxyurearesponsehemoglobinopathies
https://pubmed.ncbi.nlm.nih.gov/26719735/
Hydroxyurea decreases hospitalizations in pediatric patients with Hb SC and Hb SB+ thalassemia
This cohort of patients with Hb SC and SB+ thalassemia provides additional support for using HU in patients with recurrent hospitalizations for pain. A large...
hydroxyureapediatricpatientshbsc
https://mhealth.jmir.org/2019/8/e13452/
JMIR mHealth and uHealth - A Multidimensional Electronic Hydroxyurea Adherence Intervention for...
jmirmhealthmultidimensionalelectronichydroxyurea
https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2023.1130206/full
Frontiers | Hydroxyurea pharmacokinetics and precision dosing in low-resource settings
Introduction: Hydroxyurea is effective disease-modifying treatment for sickle cell anemia (SCA). Escalation to maximum tolerated dose (MTD) achieves superior...
frontiershydroxyureapharmacokineticsprecisiondosing